This describes the innovative aspect that test results can be acted on more quickly than waiting for standard laboratory tests and could help reduce colonoscopies and clinical appointments.
- info@buhlmannlabs.ch
- +41 61 487 12 12
Blog Archives
BÜHLMANN has launched the first Adalimumab trough level rapid test for serum samples. Easy to use, CE marked on the trusted Quantum Blue® technology platform, quantitative and highly correlating to ELISA methods.
Yet another successful introduction of BÜHLMANN fCAL® turbo calprotectin measurements. A user report from the Republic of Ireland.
At the Biochemistry Department at Mercy University Hospital (MUH) in Cork the fCAL® turbo test was successfully introduced on the Abbott Architect C8000 analyzer.
We have developed and implemented a new data-driven, programmatic approach to the analysis of flow cytometry data from basophil activation testing.
Social Links